Evolution of vancomycin-resistant Enterococcus faecium during colonization and infection in immunocompromised pediatric patients

Gayatri Shankar Chilambi,Hayley R. Nordstrom,Daniel R. Evans,Jose A. Ferrolino,Randall T. Hayden,Gabriela M. Marón,Anh N. Vo,Michael S. Gilmore,Joshua Wolf,Jason W. Rosch,Daria Van Tyne
DOI: https://doi.org/10.1073/pnas.1917130117
IF: 11.1
2020-05-11
Proceedings of the National Academy of Sciences
Abstract:Significance Immunocompromised patients are at increased risk for multidrug-resistant infections, due to broad-spectrum antibiotic exposure and a host environment with limited innate defenses. This study explored how vancomycin-resistant Enterococcus faecium (VREfm), a pathogen endemic to many hospitals, underwent genomic and phenotypic changes during intestinal colonization and bloodstream infection of immunocompromised pediatric patients. We identified a mutation conferring bacterial growth in alternative sugars that arose de novo in two different patients and was also present in five other patients. We also characterized mutations in surface polysaccharide production associated with better adherence to surfaces and resistance to the innate immune factor lysozyme. These findings suggest that targeting carbohydrate availability and bacterial adherence may be worthwhile strategies to limit VREfm proliferation in immunocompromised hosts.
What problem does this paper attempt to address?